Indian pharmaceutical companies are staring at a possible write-off of their receivables from Sri Lanka, as they are struggling to repatriate money from the South Asian island country which is facing severe dollar crunch and a devaluation of local currency due to ongoing economic crisis. One of India’s leading drug …
Read More »Indian pharma industry estimated to grow 9-11% in 2021-22: ICRA
The Indian pharma industry is estimated to grow at 9-11 per cent in 2021-22 and in the next few quarters, it will be driven by domestic and emerging markets, according to ratings agency ICRA. In a sample of 21 Indian pharmaceutical companies, said revenue growth was moderate at 6.4 per …
Read More »Strides Pharma says could take 3-4 qtrs for normalcy of US business hit price erosion
said it would take at least three to four quarters for its US business operations to return to normalcy, which was hit by price erosion of its base business, which was as high as 40%. The company now has pushed its US revenue guidance of $225 – $250 million FY22 …
Read More »Gland Pharma gets tentative nod from USFDA for generic Sugammadex injection
Drug firm Gland Pharma on Friday said it has received a tentative nod from the US health regulator for generic Sugammadex injection, which is indicated for reversing the effects of the muscle relaxants rocuronium bromide and vecuronium bromide given to patients during surgery. The company “has received tentative approval from …
Read More »Doceree launches opti-channel marketing to open digital route for pharma companies, Health News, ET HealthWorld
New Delhi: Doceree launches opti-channel marketing in an attempt to accelerate adoption of digital mediums and to ease the process for the pharmaceutical companies to reach out to physicians via different communication means such as Emails, messages and other communication platforms. Moving out from single-channel communication to opti-channel marketing will …
Read More »Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG, Health News, ET HealthWorld
Drug firm Mankind Pharma on Thursday said it has received licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19. 2-DG was developed by the Defence Research and Development Establishment (DRDE), Gwalior. The clinical trials were conducted by …
Read More »Mankind Pharma inks distribution pact with BDR Pharmaceuticals for COVID drug
Mankind Pharma on Thursday said it has inked a pact with BDR Pharmaceuticals for distributing Baricitinib, a drug that is used in COVID treatment. The product, which would be sold under the BARIKIND trademark, has received restricted emergency use approval for use in combination with remdesivis in the treatment of …
Read More »